Changzhou Qianhong Biopharma Co (SZSE:002550) Receivables Turnover : 1.22 (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Changzhou Qianhong Biopharma Co's Revenue for the three months ended in Sep. 2024 was ¥352 Mil. Changzhou Qianhong Biopharma Co's average Accounts Receivable for the three months ended in Sep. 2024 was ¥288 Mil. Hence, Changzhou Qianhong Biopharma Co's Receivables Turnover for the three months ended in Sep. 2024 was 1.22.

Changzhou Qianhong Biopharma Co Receivables Turnover Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co Receivables Turnover Chart

Changzhou Qianhong Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

4.66

4.10

4.78

4.80

4.59

Changzhou Qianhong Biopharma Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Receivables Turnover	Get a 7-Day Free Trial															1.26	1.40	1.83	1.35	1.22

Competitive Comparison of Changzhou Qianhong Biopharma Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Changzhou Qianhong Biopharma Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Changzhou Qianhong Biopharma Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changzhou Qianhong Biopharma Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Changzhou Qianhong Biopharma Co's Receivables Turnover falls into.

Changzhou Qianhong Biopharma Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Changzhou Qianhong Biopharma Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	1814.269	/ (	(565.08	+	225.032)	/	2 )
=	1814.269	/	395.056
=	4.59

Changzhou Qianhong Biopharma Co's Receivables Turnover for the quarter that ended in Sep. 2024 is calculated as

	Receivables Turnover (Q: Sep. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2024 )	/ (	(Accounts Receivable (Q: Jun. 2024 )	+	Accounts Receivable (Q: Sep. 2024 ))	/	count )
=	352.007	/ (	(305.983	+	270.788)	/	2 )
=	352.007	/	288.3855
=	1.22

Changzhou Qianhong Biopharma Co (SZSE:002550) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Changzhou Qianhong Biopharma Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Changzhou Qianhong Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Receivables Turnover

Traded in Other Exchanges

N/A

Address

Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022

Website

http://www.qhsh.com.cn

Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Executives

Huang Jie	Executives
Wang Ke	Directors, executives
Jiang Wen Qun	Supervisors
Zou Shao Bo	Executives
Wei Li Jun	Executives
Mei Chun Wei	Executives
Zhou Xiang	Directors, executives
Zhao Gang	Director
Ye Hong Ping	Executives
Liu Jun	Director
Fan Yong	Executives
Jiang Jian Ping	Supervisors
Wang Yao Fang	Director
Hai Tao	Directors, executives
Wang Yi	Director

Changzhou Qianhong Biopharma Co Headlines

No Headlines